... fell 9 percent, and the Nasdaq Biotech Index was down 3 percent. ... Exact also presented data at the San Antonio Breast Cancer Symposium in ...
News
- GenomeWeb Top 40 Down 3 Percent in December, Though More Resilient Than Broader Market
- Hera Biotech Announces First Patient Enrolled in Endometriosis Diagnostic Study | Business
SAN ANTONIO--(BUSINESS WIRE)--Jan 3, 2023--. The first patient for the proof-of-concept multi-center clinical trial of the MetriDx™ endometriosis ...
- Hera Biotech Announces First Patient Enrolled in Endometriosis Diagnostic Study
SAN ANTONIO--(BUSINESS WIRE)--The first patient for the proof-of-concept multi-center clinical trial of the MetriDx™ endometriosis diagnostic test ...
- Two books give San Antonio an a-maze-ing remake | TPR - Texas Public Radio
“We highlight a lot of the local historic landmarks with our rich, authentic heritage in San Antonio. The five San Antonio Missions, the World ...
- 360Dx Top 30 Ends 2022 With 2 Percent Dip in December
The Nasdaq Biotech Index also fell 3 percent. ... price due to new data presented at the 2022 San Antonio Breast Cancer Symposium last month.